AstraZeneca and Ionis are planning a US launch next month for Wainua, their treatment for polyneuropathy in life-threatening disease transthyretin-mediated amyloidosis (ATTR), after getting FDA ...

Despite years of ongoing research, the prognosis for patients diagnosed with these conditions is generally poor. To date, studies have explored the role of MEMRI in context of tauopathies, PD and ALS.

Multiple myeloma is part of the spectrum of diseases ranging from MGUS to plasma cell leukemia, and similar to MGUS, is characterized by proliferation of a plasma cell clone and subsequent ...